Observational Study for Kidney Transplant Patients
An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
- Age
- 18 – 70
- Sex
- Any
- Study type
- Observational
- Participants needed
- 20 (estimated)
- Sponsor
- Regeneron Pharmaceuticals · Industry
This trial is looking for adult patients who have received a kidney transplant and were treated with vonsetamig in a previous study. Participants will be monitored to see how their body responds after the transplant, but no study drug will be given during this trial.
You may be able to join if
- I have received at least 1 dose of vonsetamig in a prior study.
- I received a kidney transplant while enrolled in a previous study.
- I am willing and able to attend clinic visits.
- I will provide signed informed consent.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe main purpose of this study is to continue to see how vonsetamig works in the body and to monitor the outcomes after kidney transplant for participants previously treated in the R5459-RT-1944 study (NCT05092347). No study drug will be given during this study.
Loading trial locations…